Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Proceedings of Spie--The International Society for Optical Engineering
|
August 1, 2014
Peripheral Quantitative CT (pQCT) Using a Dedicated Extremity Cone-Beam CT Scanner
A A Muhit, S Arora, M Ogawa, et al.
Annals of the Rheumatic Diseases
|
May 12, 2016
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
P Emery, C O Bingham, G R Burmester, et al.
Rheumatology (Oxford, England)
|
January 8, 2008
Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel
D E Furst, R J Halbert, C O Bingham, et al.
Seminars in Arthritis and Rheumatism
|
December 23, 2023
Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group
D Saygin, D DiRenzo, J Raaphorst, et al.
Journal for Immunotherapy of Cancer
|
November 23, 2017
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I Puzanov, A Diab, K Abdallah, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Proceedings of Spie--The International Society for Optical Engineering
|
August 1, 2014
Peripheral Quantitative CT (pQCT) Using a Dedicated Extremity Cone-Beam CT Scanner
A A Muhit, S Arora, M Ogawa, et al.
Annals of the Rheumatic Diseases
|
May 12, 2016
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
P Emery, C O Bingham, G R Burmester, et al.
Rheumatology (Oxford, England)
|
January 8, 2008
Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel
D E Furst, R J Halbert, C O Bingham, et al.
Seminars in Arthritis and Rheumatism
|
December 23, 2023
Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group
D Saygin, D DiRenzo, J Raaphorst, et al.
Journal for Immunotherapy of Cancer
|
November 23, 2017
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I Puzanov, A Diab, K Abdallah, et al.
Page
of 3